Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 26,221 | 30,227 | 30,013 | 15,198 | 40,414 |
| Cost of Goods | 303 | 334 | 702 | 695 | N/A |
| Gross Profit | 25,918 | 29,893 | 29,311 | 14,503 | 40,414 |
| Operating Expenses | 140,082 | 127,710 | 126,369 | 114,360 | 113,363 |
| Operating Income | -113,861 | -97,483 | -96,356 | -99,162 | -72,949 |
| Other Income | 3,990 | 4,405 | 4,562 | 4,498 | 4,204 |
| Pre-tax Income | -109,871 | -93,078 | -91,794 | -94,664 | -68,745 |
| Net Income Continuous | -109,871 | -93,078 | -91,794 | -94,664 | -68,745 |
| Net Income | $-109,871 | $-93,078 | $-91,794 | $-94,664 | $-68,745 |
| EPS Basic Total Ops | -1.87 | -1.59 | -1.58 | -1.63 | -1.19 |
| EPS Basic Continuous Ops | -1.87 | -1.59 | -1.57 | -1.63 | -1.19 |
| EPS Diluted Total Ops | -1.87 | -1.59 | -1.58 | -1.63 | -1.19 |
| EPS Diluted Continuous Ops | -1.87 | -1.59 | -1.57 | -1.63 | -1.19 |
| EBITDA(a) | $-112,712 | $-96,609 | $-95,742 | $-98,614 | $-72,095 |